A study of nutrient innervation in pancreatic cancer found that TRK-NGF inhibitors could interfere with the axon–nerve axis and reduce the nutrient supply of PDAC to reduce tumor recurrence (38, 51). This evidence concerns the gene NGF and neoplasm.